Get startedLog in
    Picture of JCR Pharmaceuticals logo

    4552 — JCR Pharmaceuticals News Story

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    All News

    Brief: JCR Says Acumen Exercises Exclusive Option For Up To Two Alzheimer's Candidates

    Picture of JCR Pharmaceuticals logoJCR Pharmaceuticals
    17/06/2026 19:00
    BRIEF-JCR Says Acumen Exercises Exclusive Option For Up To Two Alzheimer's Candidates
    June 17 (Reuters) - JCR Pharmaceuticals Co Ltd 4552.T:
    • JCR PHARMACEUTICALS CO - ACUMEN PHARMACEUTICALS EXERCISES EXCLUSIVE OPTION FOR UP TO TWO ALZHEIMER'S DISEASE CANDIDATES WITH JCR
    • JCR PHARMACEUTICALS CO - ACUMEN'S EBD PROGRAM ON TRACK FOR IND FILING IN MID-2027
    • JCR PHARMACEUTICALS CO - ELIGIBLE FOR UP TO $555 MILLION IN MILESTONE PAYMENTS FROM ACUMEN DEAL
    • JCR PHARMACEUTICALS CO - TO RECEIVE TIERED ROYALTIES ON NET SALES FROM COLLABORATION PRODUCTS
    Source text: ID:nBw2fND6ra
    Further company coverage: 4552.T

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on JCR Pharmaceuticals

    See all news